Singapore HSA registration DE0507554

Diasorin LIAISON Measles IgG

Singapore flagSingapore·CLASS C IVD·DiaSorin Italia S.p.A.·Registered November 29, 2022
Device classification
Device Class
CLASS C IVD
Medical Speciality Area
Immunology
Registration information
Registration Number
DE0507554
Registration Date
November 29, 2022
Change Notification Approval Date
May 20, 2024
Retention Due Date
November 28, 2025
Product description
The LIAISON® Measles IgG assay uses chemiluminescence immunoassay (CLIA) technology for the semi- quantitative determination of specific IgG antibodies to measles virus in human serum samples. It is intended to be used as an aid in the determination of serological status to measles virus. The test has to be performed on the LIAISON® Analyzer family.
Product Owner
Short Name
DiaSorin Italia S.p.A.
Address
Via Crescentino, snc, 13040 Saluggia (VC) Italy, ITALY
Registrant
Address
100H PASIR PANJANG ROAD, OC@PASIR PANJANG, #07-01, SINGAPORE 118524
Importer
Address
100H PASIR PANJANG ROAD, OC@PASIR PANJANG, #07-01, SINGAPORE 118524
Model information
Model Name(s)
LIAISON Measles IgG LIAISON Control Measles IgG
Model Identifier(s)
318810 318811
About this record

Access comprehensive regulatory information for Diasorin LIAISON Measles IgG in the Singapore medical device market through Pure Global AI's free database. This CLASS C IVD medical device is registered under HSA registration number DE0507554 and owned by DiaSorin Italia S.p.A.. The device was registered on November 29, 2022.

This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.

Free DatabasePowered by Pure Global AIHSA Official DataCLASS C IVD